Skip to Content Skip to Navigation

Over ons Praktische zaken Waar vindt u ons prof. dr. E.P. (Eugène) van Puijenbroek

prof. dr. E.P. (Eugène) van Puijenbroek

Bijzonder hoogleraar Geneesmiddelenbewaking en geneesmiddelenveiligheid namens het Nederlands Bijwerkingen Fonds

Profielfoto van prof. dr. E.P. (Eugène) van Puijenbroek

Faculteit Science and Engineering

Telefoon:

050 36 37576 (Secretariaat)

Nederlands Bijwerkingen Centrum Lareb:

073 646 9700 (Secretariaat)

e.vanpuijenbroek lareb.nl

E-mail:

e.p.van.puijenbroek rug.nl

ORCID Research Portal

Publicaties

Burden of non-serious infections during biological use for rheumatoid arthritis

Bergmans, B., Jessurun, N., van Lint, J., Murk, J-L., van Puijenbroek, E. & de Vries, E., 2024, In: PLoS ONE. 19, 2, 16 blz., e0296821.

Onderzoeksoutput › › peer review

How could employing the patient perspective transform pharmacovigilance?

van den Bemt, P. M. L. A., van Puijenbroek, E. P. & van Hunsel, F. P. A. M., 26-jun.-2024, (E-pub ahead of print) In: Expert Opinion on Drug Safety. 10 blz.

Onderzoeksoutput › › peer review

Improving Data Collection in Pregnancy Safety Studies: Towards Standardisation of Data Elements in Pregnancy Reports from Public and Private Partners, A Contribution from the ConcePTION Project

Favre, G., Richardson, J. L., Moore, A., Geissbühler, Y., Jehl, V., Oliver, A., Shechtman, S., Diav-Citrin, O., Berlin, M., De Haan, T., Baud, D., Panchaud, A., Mor, A., Sabidó, M., de Souza, S., Chambers, C., van Rijt-Weetink, Y. R. J., van Puijenbroek, E. P., Yates, L. M., Girardin, F., & 2 anderenStellfeld, M. & Winterfeld, U., mrt.-2024, In: Drug Safety. 47, blz. 227–236 10 blz.

Onderzoeksoutput › › peer review

Medication errors by caregivers in the homes of children discharged from a pediatric department in Ghana

Sabblah, G. T., van Hunsel, F., Taxis, K., Duwiejua, M., Seaneke, S. K. & van Puijenbroek, E., 2024, In: Therapeutic advances in drug safety. 15, 13 blz.

Onderzoeksoutput › › peer review

Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis

Raschi, E., Salvo, F., Bate, A., De Ponti, F., Poluzzi, E., Tuccori, M., van Puijenbroek, E., Joshi, N. & Khouri, C., 18-mrt.-2024, (E-pub ahead of print) In: Drug Safety. 5 blz.

Onderzoeksoutput › › peer review

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement

Fusaroli, M., Salvo, F., Begaud, B., AlShammari, T. M., Bate, A., Battini, V., Brueckner, A., Candore, G., Carnovale, C., Crisafulli, S., Cutroneo, P. M., Dolladille, C., Drici, M-D., Faillie, J-L., Goldman, A., Hauben, M., Herdeiro, M. T., Mahaux, O., Manlik, K., Montastruc, F., & 14 anderenNoguchi, Y., Norén, G. N., Noseda, R., Onakpoya, I. J., Pariente, A., Poluzzi, E., Salem, M., Sartori, D., Trinh, N. T. H., Tuccori, M., van Hunsel, F., van Puijenbroek, E., Raschi, E. & Khouri, C., jun.-2024, In: Drug Safety. 47, 6, blz. 575-584 10 blz.

Onderzoeksoutput › › peer review

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

Fusaroli, M., Salvo, F., Begaud, B., AlShammari, T. M., Bate, A., Battini, V., Brueckner, A., Candore, G., Carnovale, C., Crisafulli, S., Cutroneo, P. M., Dolladille, C., Drici, M-D., Faillie, J-L., Goldman, A., Hauben, M., Herdeiro, M. T., Mahaux, O., Manlik, K., Montastruc, F., & 14 anderenNoguchi, Y., Norén, G. N., Noseda, R., Onakpoya, I. J., Pariente, A., Poluzzi, E., Salem, M., Sartori, D., Trinh, N. T. H., Tuccori, M., van Hunsel, F., van Puijenbroek, E., Raschi, E. & Khouri, C., jun.-2024, In: Drug Safety. 47, 6, blz. 585-599 15 blz.

Onderzoeksoutput › › peer review

Validation of a Novel Method to Assess the Clinical Quality of Information in Pregnancy-Related Pharmacovigilance Case Reports: A ConcePTION Project

van Rijt-Weetink, Y. R. J., Egberts, T. C. G., van Hunsel, F. P. A. M., Lewis, D. J., Yates, L. M., Winterfeld, U. & van Puijenbroek, E. P., mrt.-2024, In: Drug Safety. 47, blz. 261-270 10 blz.

Onderzoeksoutput › › peer review

A case series of bacillus Calmette-Guérin scar reactivation after administration of both mRNA and viral vector COVID-19 vaccines

van Balveren, L., van Puijenbroek, E. P., Davidson, L. & van Hunsel, F., jul.-2023, In: British Journal of Clinical Pharmacology. 89, 7, blz. 2113-2121 9 blz.

Onderzoeksoutput › › peer review

Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project

Richardson, J. L., Moore, A., Bromley, R. L., Stellfeld, M., Geissbühler, Y., Bluett-Duncan, M., Winterfeld, U., Favre, G., Alexe, A., Oliver, A. M., van Rijt-Weetink, Y. R. J., Hodson, K. K., Rezaallah, B., van Puijenbroek, E. P., Lewis, D. J. & Yates, L. M., 28-mrt.-2023, In: Drug Safety. 46, 5, blz. 479-491 13 blz.

Onderzoeksoutput › peer review

Alle (329) publicaties

Pers/media

Niederlande: Untersuchung zu Übersterblichkeit mangelhaft

van Puijenbroek, E.

15/09/2022

Pers / media: Expert Comment ›

Hoe weet je of een depressie het gevolg is van medicatie?

Puijenbroek, van, E.

24/11/2016

Pers / media: Expert Comment ›

Alle (2) pers/media

Bekijk volledig onderzoeksprofiel

Volg de RUGfacebook twitter linkedin rss instagram youtube